Camac Fund, LP's Form 4 filing
Pasithea Therapeutics Corp. (KTTA) · filed Aug 18, 2022
- Accession no.
- 0001493152-22-023502
- Filed
- Aug 18, 2022, 7:35 PM ET
- Trade date
- Aug 17, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $188.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Camac Fund, LPCIK 0001516478 | Other: Member of 10% owner group. |
| Shahinian EricCIK 0001790877 | Other: Member of 10% owner group |
| Camac Partners, LLCCIK 0001867496 | Other: Member of 10% owner group. |
| Camac Capital, LLCCIK 0001867498 | Other: Member of 10% owner group. |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +155,773 | $1.21 | +$188,282.83 | 1,611,329 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.